Fox Chase Cancer Center Welcomes Dr. Michael Scott

Michael Scott, MD, an assistant professor at Fox Chase in the Supportive Oncology and Palliative Care Program
Michael Scott, MD, an assistant professor at Fox Chase in the Supportive Oncology and Palliative Care Program

PHILADELPHIA (August 15, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Michael Scott, MD, who will be joining the Supportive Oncology and Palliative Care Program in the Department of Hematology/Oncology as an assistant professor.

Scott earned his undergraduate degree in chemistry and biology from West Chester University and attended the Washington University School of Medicine in St. Louis. He graduated with his medical degree in 2014 and went on to complete his residency in family medicine at the Hospital of the University of Pennsylvania. He also completed a hospice and palliative medicine fellowship at the Hospital of the University of Pennsylvania.

Prior to joining the Fox Chase faculty, Scott worked at the Helen F. Graham Cancer Center in Delaware as a clinical lead physician and as a clinical instructor at Bellevue Hospital in New York.

Scott has published multiple peer-reviewed articles over the course of his career and currently belongs to multiple professional organizations, including the American Academy of Family Physicians and the American Academy of Hospice and Palliative Medicine.

Scott has an extensive history of participation in quality improvement programs, including at the Hospital of the University of Pennsylvania’s Department of Palliative Medicine, the Hospital of the University of Pennsylvania’s Department of Geriatrics, and the Michael J. Crescenz VAMC Department of Palliative Medicine.

Scott will begin his tenure at Fox Chase on September 11.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text